Metropolis Healthcare Limited

NSE METROPOLIS.NS

Metropolis Healthcare Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 51,394,416

Metropolis Healthcare Limited Shares (Diluted, Weighted) is 51,394,416 for the year ending March 31, 2024, a 0.05% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Metropolis Healthcare Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 51,370,023, a -0.09% change year over year.
Metropolis Healthcare Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 51,414,148, a 0.49% change year over year.
Metropolis Healthcare Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 51,161,232, a 1.45% change year over year.
Metropolis Healthcare Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 50,432,294, a 0.80% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: METROPOLIS.NS

Metropolis Healthcare Limited

CEO	Mr. Surendran Chemmenkotil
IPO Date	April 15, 2019
Location	India
Headquarters	250-D, Udyog Bhavan
Employees	4,313
Sector	Healthcare
Industries Biotechnology Clinical Trials Dental Care Drugstores & Retail Pharmacies Medical Instruments Personal Care Pharmaceuticals Telehealth

Description

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Key trends

Past 5 years